Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice
Baohong, J. I; Perani, Evelyne G; Petinom, Corinne; Grosset, Jacques H.
s.l; s.n; 1996. 7 p. tab.
Não convencional em Inglês | Hanseníase | ID: han-13813
Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014.
Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Evaluation of New Antibacterial Drugs and their Combinations in a Murine Model to Identify Short Duration Alternative Chemotherapy for Leprosy.
Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis.
Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
JAAD Grand Rounds. Posttreatment lesional hyperpigmentation.
Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
[Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.